IE38555L - Colibacillosis vaccines. - Google Patents

Colibacillosis vaccines.

Info

Publication number
IE38555L
IE38555L IE732163A IE216373A IE38555L IE 38555 L IE38555 L IE 38555L IE 732163 A IE732163 A IE 732163A IE 216373 A IE216373 A IE 216373A IE 38555 L IE38555 L IE 38555L
Authority
IE
Ireland
Prior art keywords
colibacillosis
vaccines
piglet
vaccine
colibacillosis vaccine
Prior art date
Application number
IE732163A
Other versions
IE38555B1 (en
Original Assignee
Rit Rech Ind Therapeut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rit Rech Ind Therapeut filed Critical Rit Rech Ind Therapeut
Publication of IE38555L publication Critical patent/IE38555L/en
Publication of IE38555B1 publication Critical patent/IE38555B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

1401588 Piglet colibacillosis vaccine RECHERCHE ET INDUSTRIE THERAPEUTIQUES 28 Nov 1973 [4 Dec 1972] 55187/73 Heading A5B A piglet colibacillosis vaccine for intramuscular or subcutaneous administration to pregnant sows comprises an effective amount of cell-free heat-labile (L.T.) E. Coli enterotoxin and an adjuvant. [GB1401588A]
IE2163/73A 1972-12-04 1973-11-29 Vaccine and method for its production IE38555B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31199872A 1972-12-04 1972-12-04

Publications (2)

Publication Number Publication Date
IE38555L true IE38555L (en) 1974-06-04
IE38555B1 IE38555B1 (en) 1978-04-12

Family

ID=23209403

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2163/73A IE38555B1 (en) 1972-12-04 1973-11-29 Vaccine and method for its production

Country Status (16)

Country Link
JP (1) JPS5713527B2 (en)
BE (1) BE808122A (en)
CA (1) CA1018889A (en)
CH (1) CH590928A5 (en)
DD (1) DD109029A5 (en)
DE (1) DE2360118C3 (en)
DK (1) DK141955B (en)
ES (1) ES421094A1 (en)
FR (1) FR2208648B1 (en)
GB (1) GB1401588A (en)
HK (1) HK679A (en)
HU (1) HU169138B (en)
IE (1) IE38555B1 (en)
MY (1) MY7900152A (en)
NL (1) NL177079C (en)
ZA (1) ZA738364B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2547224A1 (en) * 1974-11-01 1976-05-13 Sandoz Ag ORGANIC COMPOUNDS, THEIR USE AND MANUFACTURING
GB1560934A (en) * 1975-05-07 1980-02-13 Unilever Ltd Methods for the resistance of non-human mammals to gastro-intestinal disorders
FR2466251B1 (en) * 1979-10-03 1983-03-18 Agronomique Inst Nat Rech ANTI-COLIBACILLAR VACCINE, OBTAINMENT AND APPLICATION
DE69027112T2 (en) * 1989-01-23 1997-01-09 Auspharm International Ltd 4Th VACCINE COMPOSITION
US10441717B2 (en) 2014-04-15 2019-10-15 Insulet Corporation Monitoring a physiological parameter associated with tissue of a host to confirm delivery of medication
JP7072990B2 (en) 2018-06-22 2022-05-23 株式会社ミツトヨ Measuring device and measuring method
US11241532B2 (en) 2018-08-29 2022-02-08 Insulet Corporation Drug delivery system with sensor having optimized communication and infusion site

Also Published As

Publication number Publication date
GB1401588A (en) 1975-07-16
ZA738364B (en) 1974-09-25
NL177079B (en) 1985-03-01
BE808122A (en) 1974-06-04
HU169138B (en) 1976-09-28
CH590928A5 (en) 1977-08-31
MY7900152A (en) 1979-12-31
DE2360118A1 (en) 1974-06-06
DK141955B (en) 1980-07-28
DE2360118C3 (en) 1980-12-18
JPS4986530A (en) 1974-08-19
AU6236473A (en) 1975-05-15
CA1018889A (en) 1977-10-11
JPS5713527B2 (en) 1982-03-17
NL177079C (en) 1985-08-01
NL7316050A (en) 1974-06-06
ES421094A1 (en) 1976-04-01
HK679A (en) 1979-01-12
FR2208648A1 (en) 1974-06-28
FR2208648B1 (en) 1977-09-02
DE2360118B2 (en) 1980-04-30
IE38555B1 (en) 1978-04-12
DD109029A5 (en) 1974-10-12

Similar Documents

Publication Publication Date Title
CA1027554A (en) PREPARATION OF 7.beta.-(.alpha.-ETHERIFIED OXIMINO) ACYLAMIDO-CEPH-3-EM-4-CARBOXYLIC ACIDS
IE791618L (en) Pasteurellosis vaccines.
SE8405929D0 (en) PHARMACEUTICAL COMPOSITION
GB1510100A (en) Vaccines
IE38555L (en) Colibacillosis vaccines.
IE37602L (en) Cyclocpentane derivatives
ES475509A1 (en) Pneumococcal vaccine and a process for its preparation.
DE2961091D1 (en) E. coli enterotoxin vaccine for veterinary & human use and process for its preparation
DK0692974T3 (en) Multicomponent clostridium vaccines where saponin is used as an adjuvant
CA934295A (en) Vaccine for immunization of poultry against marek's disease
CA918071A (en) Diethylaminoethyl dextran as an adjuvant for vaccines for active immunization
GB1354075A (en) Killed vaccine for infectious porcine atrophic rhinitis and process for preparing the same
CA980251A (en) Adjuvants for vaccines and vaccine preparations containing them
CA958641A (en) Equine strangles vaccine and method of preparing and using the same
GB1390467A (en) Vaccination method using temperature sensitive virus mutants
GB1460309A (en) Tetanus toxoid and process for its manufacture
CA992980A (en) .alpha.-AMINO-.beta.-(N-BENZYLTHIOCARBAMOYLTHIO) PROPIONIC ACID AND THERAPEUTIC COMPOSITIONS
OA03800A (en) Method of preparing a novel water-free smallpox vaccine and applicable direction.
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
GB1139242A (en) Therapeutic compositions for counteracting haemorrhage
AU3635271A (en) Immunizing vaccine for immunization of dogs against kennel cough
Petrov et al. Synthetic immunogens prepared from enterobacteria. Communication I. Immunogenicity of Salmonella typhimurium O-polysaccharide conjugated with synthetic polyelectrolytes.
AU2793971A (en) Marek's disease inactivated vaccine and process for preparing the same
AU442172B2 (en) Diethylaminoethyldextran (dead-d) as adjuvant for vaccines for active immunisation
CA888154A (en) Pharmaceutical preparations having vitamin p activity comprising phenol acids